Apheresis Equipment Market - Global Forecast 2025-2032

The apheresis equipment market is undergoing substantial change, shaped by rapid technological advancements, broader clinical adoption, and an evolving regulatory environment. Senior decision-makers require clear, actionable insights to anticipate developments and guide strategic investments in this dynamic health sector.

Market Snapshot: Apheresis Equipment Market Growth & Industry Dynamics

The apheresis equipment market demonstrated robust expansion, growing from USD 3.15 billion in 2024 to USD 3.45 billion in 2025, and is projected to reach USD 6.45 billion by 2032 with a CAGR of 9.34%. This upward trend reflects strong momentum driven by increased automation, digital integration, and the broadening adoption of apheresis in cell therapy, immunotherapy, and advanced patient care applications.

Scope & Segmentation Across the Apheresis Equipment Market

• Product Types: The market encompasses apheresis kits and accessories, cell separator systems, pathogen inactivation systems, and plasma separation systems, each serving distinct clinical and operational needs.
• Applications: Key use cases include cell collection for therapies such as CAR T cell and stem cell procedures, plasma donation from single and source donors, applications in both research and therapeutic apheresis for diverse patient populations.
• End Users: Major users span blood centers, general and specialty clinics, hospitals, along with academic and commercial research institutes, representing a spectrum of care settings and study environments.
• Technology: Utilization includes centrifugal technologies in both fully and semi-automated configurations, as well as membrane technology supporting batch and continuous flow systems. These enhance flexibility and workflow efficiencies in clinical operations.
• Patient Type: Solutions address the needs of both adult and pediatric patient groups, reflecting the sector’s commitment to comprehensive patient care.
• Regions: The market covers North and South America, including the United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, and Peru; Europe, covering the United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, and Switzerland; the Middle East, including United Arab Emirates, Saudi Arabia, Qatar, Turkey, and Israel; Africa, including South Africa, Nigeria, Egypt, and Kenya; and Asia-Pacific, with China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, and Taiwan.

Key Takeaways: Strategic Insights for Decision-Makers

• Advanced automation and digital-health system integrations are improving apheresis procedures and elevating patient safety across multiple healthcare settings.
• Growth in cell therapy and immunotherapy protocols has increased demand for adaptable, precision-driven equipment, putting a stronger focus on modular system design and compliance with evolving regulatory demands.
• Demographic shifts and the rise in chronic conditions are strengthening requirements for therapeutic and pediatric apheresis, promoting product innovation for emerging healthcare needs.
• Heightened attention to environmental responsibility is fostering greater adoption of sustainable materials and modern waste management practices throughout the device lifecycle and supply chain.
• Manufacturers and biotechnology firms are prioritizing partnerships with clinical research centers, driving innovation, and expediting the validation process for new apheresis systems.

Tariff Impact: Navigating US Policy Shifts

The implementation of revised US tariffs in 2025 is prompting review and adaptation of supply chain models. Manufacturers of key devices and components, including centrifuge assemblies and disposable kits, are facing elevated landed costs. In response, stakeholders are exploring dual-sourcing arrangements, nearshoring production, and leveraging advanced tariff compliance systems, aiming to preserve supply reliability and financial stability amid trade-policy uncertainties.

Methodology & Data Sources: Reliable Market Insight

This report combines thorough secondary research from peer-reviewed journals, industry white papers, and official regulatory materials with primary interviews involving manufacturing, clinical, supply chain, and regulatory professionals. Quantitative survey findings are triangulated with qualitative input and expert panel validation to ensure accuracy and market relevance.

Apheresis Equipment Market: Why This Report Matters

• Assists leadership in identifying and capitalizing on promising market segments as they evolve by technology, application, or region.
• Provides guidance on implementing risk management and supply chain resilience strategies in a changing regulatory and trade landscape.
• Equips executive teams with competitive intelligence to synchronize investment planning and growth initiatives with sector trajectories.

Conclusion

In an evolving apheresis equipment market, leaders can apply these insights to coordinate innovation, regulatory compliance, and strategic operations. Proactive responses and targeted collaboration will shape successful outcomes for industry stakeholders.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.